On February 7, 2022 Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, reported that the Company will participate in the 2022 BIO CEO & Investor Conference on February 14-17, 2022 (Press release, Cyclacel, FEB 7, 2022, View Source [SID1234607797]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference details can be found below:

BIO CEO & Investor Conference: virtual meetings and on-demand presentation (available on conference site February 11, 2022)
Date: 1-on-1 virtual meetings with senior management February 14-17, 2022
Registration Link
The presentation can be accessed for 90 days and can be found on the Cyclacel website at www.cyclacel.com.